U.S. Healthcare Technologies Trade Mission, 14445-14447 [E5-1235]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 54 / Tuesday, March 22, 2005 / Notices
This notice is issued and published in
accordance with sections 751(a)(1) and
777(i)(l) of the Tariff Act of 1930, as
amended, and 19 CFR 351.213(d)(4).
Dated: March 16, 2005.
Barbara E. Tillman,
Acting Deputy Assistant Secretary for Import
Administration.
[FR Doc. E5–1250 Filed 3–21–05; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
International Trade Administration
[A–570–867]
Extension of Time Limit for the
Preliminary Results of the
Antidumping Duty Administrative
Review: Automotive Replacement
Glass Windshields from the People’s
Republic of China
Import Administration,
International Trade Administration,
Department of Commerce.
EFFECTIVE DATE: March 22, 2005.
FOR FURTHER INFORMATION CONTACT: Jon
Freed or Will Dickerson, Import
Administration, International Trade
Administration, U.S. Department of
Commerce, 14th Street and Constitution
Avenue, NW, Washington, DC 20230;
telephone: (202) 482–3818, or 482–1778,
respectively.
AGENCY:
Background
On May 27, 2004, the Department
published in the Federal Register a
notice of the initiation of the
antidumping duty administrative review
of automotive replacement glass
windshields from the People’s Republic
of China for the period April 1, 2003,
through March 31, 2004. See Initiation
of Antidumping and Countervailing
Duty Administrative Reviews and
Request for Revocation in Part, 69 FR
30282 (May 27, 2004). On October 12,
2004, the Department published in the
Federal Register a notice rescinding the
administrative review of two companies
which had withdrawn their requests for
reviews. See Notice of Partial Rescission
of the Antidumping Duty Administrative
Review: Certain Automotive
Replacement Glass Windshields from
the People’s Republic of China, 69 FR
60612 (October 12, 2004). On December
3, 2004, the Department published in
the Federal Register a notice extending
the time limit for the preliminary results
of the administrative review from
December 31, 2004, to March 31, 2005.
See Extension of Time Limit for the
Preliminary Results of the Antidumping
Duty Administrative Review:
VerDate jul<14>2003
15:26 Mar 21, 2005
Jkt 205001
Automotive Replacement Glass
Windshields from the People’s Republic
of China, 69 FR 70224 (December 3,
2004). The preliminary results of review
are currently due no later than March
31, 2005.
Extension of Time Limit of Preliminary
Results
Section 751(a)(3)(A) of the Tariff Act
of 1930, as amended (‘‘the Act’’), states
that, if it is not practicable to complete
the review within the time specified, the
administering authority may extend the
245-day period to issue its preliminary
results by up to 120 days. Completion
of the preliminary results of this review
within the 245-day period is not
practicable because the Department
needs additional time to analyze a
significant amount of information
pertaining to verification of one
company’s questionnaire responses and
to review supplemental questionnaire
responses of a second company.
Because it is not practicable to
complete this review within the time
specified under the Act, we are
extending the time limit for issuing the
preliminary results of review by an
additional 30 days, in accordance with
section 751(a)(3)(A) of the Act.
Therefore, as 30 days from March 31,
2005, falls on a Saturday, the
preliminary results are now due on May
2, 2005, the next business day. The final
results of review continue to be due 120
days after the date of publication of the
preliminary results.
Dated: March 15, 2005.
Barbara E. Tillman,
Acting Deputy Assistant Secretary for Import
Administration.
[FR Doc. E5–1249 Filed 3–21–05; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF COMMERCE
International Trade Administration
U.S. Healthcare Technologies Trade
Mission
International Trade
Administration, Department of
Commerce.
ACTION: Notice to U.S. Healthcare
Technologies Trade Mission to Australia
and New Zealand, September 12–16,
2005.
AGENCY:
SUMMARY: The United States Department
of Commerce, International Trade
Administration, U.S. Commercial
Service, Office of Global Trade
Programs, is organizing a Healthcare
Technologies Trade Mission to Sydney
and Melbourne, Australia and to
PO 00000
Frm 00010
Fmt 4703
Sfmt 4703
14445
Auckland, New Zealand, September 12–
16, 2005.
The trade mission will target the IThealthcare sub-sector, e.g., electronic
patient records, automated patient
scheduling, telemedicine, but will also
include other sectors within the
healthcare industry.
FOR FURTHER INFORMATION CONTACT:
Office of Global Trade Programs; Room
2012; Department of Commerce;
Washington, DC 20230; Tel: (202) 482–
4457; Fax: (202) 482–0178.
SUPPLEMENTARY INFORMATION:
HEALTHCARE TECHNOLOGIES
TRADE MISSION
Australia and New Zealand
September 12–16, 2005
Mission Statement
I. Description of the Mission
The United States Department of
Commerce, International Trade
Administration, U.S. Commercial
Service, Office of Global Trade
Programs, is organizing a Healthcare
Technologies Trade Mission to Sydney
and Melbourne, Australia and to
Auckland, New Zealand, September 12–
16, 2005.
The trade mission will target the IThealthcare sub-sector, e.g., electronic
patient records, automated patient
scheduling, telemedicine, but will also
include other sectors within the
healthcare industry.
The focus of the mission will be to
match participating U.S. companies
with qualified agents, distributors,
representatives, licensees, and joint
venture partners, and where
appropriate, arrange for appointments
with government officials, in these
markets. Consumers in Australia and
New Zealand have a strong affinity for
U.S. products.
II. Commercial Setting for the Mission
Over 85 percent of medical devices
and diagnostics used in Australia are
imported, with approximately 60
percent of these products coming from
the U.S. Other major market suppliers
are the E.U. and Japan. The Australian
medical equipment market is valued at
approximately US$2 billion,
representing about one percent of the
global medical market.
Australia is a mature market for
medical equipment, and its high per
capita income and sophisticated health
system translate into demand for a
broad range of cutting-edge medical
equipment. As in the United States,
Australians are educated consumers,
and expect state-of-the-art medical
treatment, which ensures continuous
E:\FR\FM\22MRN1.SGM
22MRN1
14446
Federal Register / Vol. 70, No. 54 / Tuesday, March 22, 2005 / Notices
demand for innovative medical
equipment and products.
Government policy and the provision
of public health services also stimulate
demand for medical equipment.
Australia has a government-funded
healthcare system, i.e., the government
(at all levels) is the primary purchaser
of medical equipment. Public hospitals
account for approximately 70 percent of
sales of medical equipment, while 30
percent of sales are made to the private
sector. As the costs of maintaining a
public healthcare system increase,
public hospital administrators and
medical staff are directed to choose the
best product available, at the lowest
possible cost.
U.S. medical equipment is
traditionally well received in Australia
due to its perceived high quality.
Opportunities are particularly strong for
state-of-the-art and innovative medical
equipment and products that can result
in significant improvement in clinical
outcomes. In particular, products that
leads to faster patient recovery, and
which reduce hospital and
rehabilitation costs, are in demand.
Additionally, health IT products are
in demand in Australia. For example,
the specialized application of IT that
enables healthcare organizations to
deliver better health outcomes have
strong sales potential. Products that
improve the delivery of services by
reducing medical errors and adverse
medical events, and increase patient
safety and satisfaction, such as health
information management systems, and
patient administration and clinical
information systems, are all
experiencing growth.
Under the Australia-U.S. Free Trade
Agreement, U.S. medical equipment
continues to receive duty-free treatment.
U.S. firms are also allowed to compete
for Australia’s government purchases on
a nondiscriminatory basis.
Commercial Setting—New Zealand
In New Zealand, 100 percent of
medical devices and diagnostics are
imported, with approximately 60
percent coming from the United States,
30 percent from Europe, and 10 percent
from Asia. The New Zealand medical
equipment market is estimated at
US$500 million.
Major hospital expansions, upgrading
and redevelopment are ongoing and are
being undertaken in the country’s most
populated areas, Auckland, Wellington
and Christchurch, driving demand for
medical equipment and services.
New Zealand’s health system is
comprised of public, private and
voluntary sectors that interact to
provide and fund health care. Presently,
VerDate jul<14>2003
15:26 Mar 21, 2005
Jkt 205001
approximately 80 percent of health care
is publicly funded and is comprised of
local General Practitioners that refer to
specialists when required. The
government provides free medical care
to children under seven. The wait for
non-critical surgery can be quite long,
and private insurance is becoming quite
popular. The increased use of privately
funded facilities provides additional
opportunities for U.S. medical
exporters. Best prospects in these
facilities include cardiac and diagnostic
equipment.
New Zealand’s total health
expenditure as a percentage of Gross
Domestic Products was recently
measured at approximately 9 percent
and had increased from the previous
period. The publicly funded portion of
health expenditures comprised the bulk
of this figure, and also increased over
the same period.
New Zealand’s aging population will
increase demand for facilities such as
retirement villages with on-site
hospitals that will require not only
medical services but also medical
equipment. Orthopedic and other
musculo-skeletal conditions have
become the major cause of disability in
New Zealand, and represent areas of
demand for U.S. medical exporters.
As in Australia, opportunities for
exporters of health IT products are
strong. Large U.S. companies in this
sector have not yet entered the New
Zealand market, so there is unmet
demand for new health IT technologies.
III. Goals for the Mission
The Trade Mission’s goal is to provide
market entry or increased sales into the
Australia and New Zealand markets for
U.S. healthcare firms and/or IT firms
with healthcare-related products or
services, as well as first-hand market
information and access to key
government officials and potential
business partners.
IV. Scenario for the Mission
The trade mission will spend two
days in Sydney, two days in Melbourne,
and one day in Auckland.
In each country, the U.S. Commercial
Service will:
• Provide a market briefing
highlighting opportunities in the
healthcare technologies sector;
• Schedule one-on-one appointments
with potential business partners for
each participant.
In Australia, the U.S. Commercial
Service will:
Arrange a hospitality event to
introduce participants to key business
and industry officials.
PO 00000
Frm 00011
Fmt 4703
Sfmt 4703
Timetable
Sunday, September 11, 2005
Arrive in Sydney
Monday, September 12, 2005
Breakfast Market Briefing in Sydney
Trade Mission Meetings in Sydney
Evening Reception
Tuesday, September 13, 2005
Trade Mission Meetings in Sydney
Travel to Melbourne
Wednesday, September 14, 2005
Breakfast Market Briefing in
Melbourne
Trade Mission Meetings in Melbourne
Evening Reception
Thursday, September 15, 2005
Trade Mission Meetings in Melbourne
Travel to Auckland
Friday, September 16, 2005
Breakfast Market Briefing in Auckland
Trade Mission Meetings in Auckland
Conclusion of Trade Mission
V. Criteria for Participant Selection
• Relevance of the company’s
business line to the mission scope and
goals
• Potential for business in the
selected markets
• Timeliness of the company’s
completed application, participation
agreement, and payment of the mission
participation fee
• Provision of adequate information
on the company’s products and/or
services and communication of the
company’s primary objectives to
facilitate appropriate matching with
potential business partners
• Certification that the company’s
products and/or services are
manufactured or produced in the United
States or if manufactured/produced
outside of the United States, the
product/service must be marketed under
the name of a U.S. firm and have U.S.
content representing at least 51 percent
of the value of the finished good or
service.
Any partisan political activities of an
applicant, including political
contributions, will be entirely irrelevant
to the selection process.
The mission will be promoted
through the following venues: Export
Assistance Centers and the Healthcare
Team; USCS Trade Events List https://
www.export.gov; industry newsletters;
the Federal Register; relevant trade
publications; relevant trade
associations; past Commerce trade
mission participants; various in-house
and purchased industry lists, and on the
Commerce Department trade missions
calendar: https://www.ita.doc.gov/doctm/
tmcal.html.
E:\FR\FM\22MRN1.SGM
22MRN1
Federal Register / Vol. 70, No. 54 / Tuesday, March 22, 2005 / Notices
Recruitment will begin immediately
and will close on July 29, 2005. The
trade mission participation fee will be
US$3,500 per company. The
participation fee does not include the
cost of travel and lodging. Participation
is open to the first 10 qualified U.S.
companies. Applications received after
that date will be considered only if
space and scheduling constraints
permit.
Contact Information
Bill Kutson, Project Manager, U.S.
Commercial Service, Global Trade
Programs, U.S. Department of
Commerce, Room 2012, Washington, DC
20230, Tel: (202) 482–2839, Fax: (202)
482–0178, E-mail:
William.Kutson@mail.doc.gov.
Dated: March 14, 2005.
Nancy Hesser,
Industry Sector Manager, Office of Trade
Event Programs.
[FR Doc. E5–1235 Filed 3–21–05; 8:45 am]
BILLING CODE 3510–DR–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
[I.D. 031705B]
Fisheries Off West Coast States and in
the Western Pacific; Pacific Coast
Groundfish Fishery; Application for an
Exempted Fishing Permit
National Marine Fisheries
Service (NMFS), National Oceanic and
Atmospheric Administration (NOAA),
Commerce.
ACTION: Notice; receipt of an exempted
fishing permit application; intent to
issue the EFP; request for comments.
AGENCY:
SUMMARY: NMFS announces the receipt
of an exempted fishing permit (EFP)
application, and the intent to issue EFPs
for vessels participating in an
observation program to monitor the
incidental take of salmon and
groundfish in the shore-based
component of the Pacific whiting
fishery. The EFPs are necessary to allow
trawl vessels fishing for Pacific whiting
to delay sorting their catch, and thus to
retain prohibited species and groundfish
in excess of cumulative trip limits until
the point of offloading. These activities
are otherwise prohibited by Federal
regulations. The EFPs will be effective
no earlier than April 1, 2005, and would
expire no later than May 31, 2006, but
could be terminated earlier under terms
and conditions of the EFPs and other
applicable laws.
VerDate jul<14>2003
15:26 Mar 21, 2005
Jkt 205001
Written comments must be
received by April 1, 2005.
ADDRESSES: Send comments or request
for copies of the EFP application to
Carrie Nordeen, Northwest Region,
NMFS, 7600 Sand Point Way NE., Bldg.
1, Seattle, WA 98115 0070 or email to
2005WhitingEFP.nwr@noaa.gov.
Comments sent via email, including all
attachments, must not exceed a 10
megabyte file size.
FOR FURTHER INFORMATION CONTACT:
Carrie Nordeen at (206) 526 6144.
SUPPLEMENTARY INFORMATION: This
action is authorized by the MagnusonStevens Fishery Conservation and
Management Act provisions at 50 CFR
600.745, which state that EFPs may be
used to authorize fishing activities that
would otherwise be prohibited. At the
November 2004 Pacific Fishery
Management Council (Pacific Council)
meeting in Portland, Oregon, NMFS
received an application for these EFPs
from the States of Washington, Oregon,
and California. An opportunity for
public testimony was provided during
the Pacific Council meeting. The Pacific
Council recommended that NMFS issue
the EFPs, as requested by the States.
NMFS is working with the States and
participants of the EFP to resolve
funding, full retention, and monitoring
issues affecting this EFP.
Issuance of these EFPs, to about 40
vessels, will continue an ongoing
program to collect information on the
incidental catch of salmon and
groundfish in whiting harvests
delivered to shore-based processing
facilities by domestic trawl vessels.
Because whiting deteriorates rapidly,
whiting must be minimally handled and
immediately chilled to maintain the
flesh quality. As a result, many vessels
dump catch directly or near directly
into the hold and are unable to
effectively sort their catch.
The issuance of EFPs will allow
vessels to delay sorting of groundfish
catch in excess of cumulative trip limits
and prohibited species until offloading.
These activities are otherwise
prohibited by regulation. In 2004,
electronic monitoring systems were
provided by NMFS to catcher vessels
participating in the whiting EFP as part
of a pilot study to evaluate if these
systems would be useful tools to verify
full retention and/or document discard
at sea. Based on the results from the
2004 pilot study, electronic monitoring
systems may be useful tools to monitor
compliance with full retention
requirements. NMFS will continue to
evaluate the usefulness of electronic
monitoring tools during the 2005
whiting EFP and will once again
DATES:
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
14447
provide electronic monitoring systems
to participating vessels.
Delaying sorting until offloading will
allow samplers located at the processing
facilities to collect incidental catch data
for total catch estimates and will enable
whiting quality to be maintained.
Without an EFP, groundfish regulations
at 50 CFR 660.306(a)(2) require vessels
to sort their prohibited species catch
and return them to sea as soon as
practicable with minimum injury.
Similarly, regulations at 50 CFR
660.306(a)(10) prohibit the retention of
groundfish in excess of the published
trip limits.
In addition to providing information
that will be used to monitor the
attainment of the shore-based whiting
allocation, information gathered through
these EFPs is expected to be used in a
future rulemaking. In the near future,
NMFS is considering implementing,
through federal regulation, a monitoring
program for the shore-based Pacific
whiting fleet. The Pacific Council
recommended using EFPs only until a
permanent monitoring program can be
developed and implemented. NMFS is
developing a preliminary draft
Environmental Assessment that
includes a range of alternative
monitoring systems for the shore-based
Pacific whiting fishery. At its June 2004
meeting, the Pacific Council considered
a preliminary range of alternatives for a
monitoring program that focus on three
major issues: (1) The monitoring
program (i.e., federal observers, state
monitors, electronic monitoring, or a
combination thereof); (2) tracking and
disposition of prohibited species and
groundfish overages; and (3)
mechanisms for funding of the
monitoring program. In summer 2005,
the Pacific Council is expected to adopt
a revised range of alternatives for public
review that cover these same issues. In
autumn 2005, the Pacific Council is
expected to make final
recommendations to NMFS regarding
this monitoring program. NMFS would
then prepare a proposed rule, which
would include a public comment
period, followed by a final rule
implementing a monitoring program
before the start of the 2006 shore-based
primary Pacific whiting season.
Authority: 16 U.S.C. 1801 et seq.
Dated: March 17, 2005.
Alan D. Risenhoover,
Acting Director, Office of Sustainable
Fisheries, National Marine Fisheries Service.
[FR Doc. E5–1248 Filed 3–21–05; 8:45 am]
BILLING CODE 3510–22–S
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 70, Number 54 (Tuesday, March 22, 2005)]
[Notices]
[Pages 14445-14447]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-1235]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
U.S. Healthcare Technologies Trade Mission
AGENCY: International Trade Administration, Department of Commerce.
ACTION: Notice to U.S. Healthcare Technologies Trade Mission to
Australia and New Zealand, September 12-16, 2005.
-----------------------------------------------------------------------
SUMMARY: The United States Department of Commerce, International Trade
Administration, U.S. Commercial Service, Office of Global Trade
Programs, is organizing a Healthcare Technologies Trade Mission to
Sydney and Melbourne, Australia and to Auckland, New Zealand, September
12-16, 2005.
The trade mission will target the IT-healthcare sub-sector, e.g.,
electronic patient records, automated patient scheduling, telemedicine,
but will also include other sectors within the healthcare industry.
FOR FURTHER INFORMATION CONTACT: Office of Global Trade Programs; Room
2012; Department of Commerce; Washington, DC 20230; Tel: (202) 482-
4457; Fax: (202) 482-0178.
SUPPLEMENTARY INFORMATION:
HEALTHCARE TECHNOLOGIES TRADE MISSION
Australia and New Zealand
September 12-16, 2005
Mission Statement
I. Description of the Mission
The United States Department of Commerce, International Trade
Administration, U.S. Commercial Service, Office of Global Trade
Programs, is organizing a Healthcare Technologies Trade Mission to
Sydney and Melbourne, Australia and to Auckland, New Zealand, September
12-16, 2005.
The trade mission will target the IT-healthcare sub-sector, e.g.,
electronic patient records, automated patient scheduling, telemedicine,
but will also include other sectors within the healthcare industry.
The focus of the mission will be to match participating U.S.
companies with qualified agents, distributors, representatives,
licensees, and joint venture partners, and where appropriate, arrange
for appointments with government officials, in these markets. Consumers
in Australia and New Zealand have a strong affinity for U.S. products.
II. Commercial Setting for the Mission
Over 85 percent of medical devices and diagnostics used in
Australia are imported, with approximately 60 percent of these products
coming from the U.S. Other major market suppliers are the E.U. and
Japan. The Australian medical equipment market is valued at
approximately US$2 billion, representing about one percent of the
global medical market.
Australia is a mature market for medical equipment, and its high
per capita income and sophisticated health system translate into demand
for a broad range of cutting-edge medical equipment. As in the United
States, Australians are educated consumers, and expect state-of-the-art
medical treatment, which ensures continuous
[[Page 14446]]
demand for innovative medical equipment and products.
Government policy and the provision of public health services also
stimulate demand for medical equipment. Australia has a government-
funded healthcare system, i.e., the government (at all levels) is the
primary purchaser of medical equipment. Public hospitals account for
approximately 70 percent of sales of medical equipment, while 30
percent of sales are made to the private sector. As the costs of
maintaining a public healthcare system increase, public hospital
administrators and medical staff are directed to choose the best
product available, at the lowest possible cost.
U.S. medical equipment is traditionally well received in Australia
due to its perceived high quality. Opportunities are particularly
strong for state-of-the-art and innovative medical equipment and
products that can result in significant improvement in clinical
outcomes. In particular, products that leads to faster patient
recovery, and which reduce hospital and rehabilitation costs, are in
demand.
Additionally, health IT products are in demand in Australia. For
example, the specialized application of IT that enables healthcare
organizations to deliver better health outcomes have strong sales
potential. Products that improve the delivery of services by reducing
medical errors and adverse medical events, and increase patient safety
and satisfaction, such as health information management systems, and
patient administration and clinical information systems, are all
experiencing growth.
Under the Australia-U.S. Free Trade Agreement, U.S. medical
equipment continues to receive duty-free treatment. U.S. firms are also
allowed to compete for Australia's government purchases on a
nondiscriminatory basis.
Commercial Setting--New Zealand
In New Zealand, 100 percent of medical devices and diagnostics are
imported, with approximately 60 percent coming from the United States,
30 percent from Europe, and 10 percent from Asia. The New Zealand
medical equipment market is estimated at US$500 million.
Major hospital expansions, upgrading and redevelopment are ongoing
and are being undertaken in the country's most populated areas,
Auckland, Wellington and Christchurch, driving demand for medical
equipment and services.
New Zealand's health system is comprised of public, private and
voluntary sectors that interact to provide and fund health care.
Presently, approximately 80 percent of health care is publicly funded
and is comprised of local General Practitioners that refer to
specialists when required. The government provides free medical care to
children under seven. The wait for non-critical surgery can be quite
long, and private insurance is becoming quite popular. The increased
use of privately funded facilities provides additional opportunities
for U.S. medical exporters. Best prospects in these facilities include
cardiac and diagnostic equipment.
New Zealand's total health expenditure as a percentage of Gross
Domestic Products was recently measured at approximately 9 percent and
had increased from the previous period. The publicly funded portion of
health expenditures comprised the bulk of this figure, and also
increased over the same period.
New Zealand's aging population will increase demand for facilities
such as retirement villages with on-site hospitals that will require
not only medical services but also medical equipment. Orthopedic and
other musculo-skeletal conditions have become the major cause of
disability in New Zealand, and represent areas of demand for U.S.
medical exporters.
As in Australia, opportunities for exporters of health IT products
are strong. Large U.S. companies in this sector have not yet entered
the New Zealand market, so there is unmet demand for new health IT
technologies.
III. Goals for the Mission
The Trade Mission's goal is to provide market entry or increased
sales into the Australia and New Zealand markets for U.S. healthcare
firms and/or IT firms with healthcare-related products or services, as
well as first-hand market information and access to key government
officials and potential business partners.
IV. Scenario for the Mission
The trade mission will spend two days in Sydney, two days in
Melbourne, and one day in Auckland.
In each country, the U.S. Commercial Service will:
Provide a market briefing highlighting opportunities in
the healthcare technologies sector;
Schedule one-on-one appointments with potential business
partners for each participant.
In Australia, the U.S. Commercial Service will:
Arrange a hospitality event to introduce participants to key
business and industry officials.
Timetable
Sunday, September 11, 2005
Arrive in Sydney
Monday, September 12, 2005
Breakfast Market Briefing in Sydney
Trade Mission Meetings in Sydney
Evening Reception
Tuesday, September 13, 2005
Trade Mission Meetings in Sydney
Travel to Melbourne
Wednesday, September 14, 2005
Breakfast Market Briefing in Melbourne
Trade Mission Meetings in Melbourne
Evening Reception
Thursday, September 15, 2005
Trade Mission Meetings in Melbourne
Travel to Auckland
Friday, September 16, 2005
Breakfast Market Briefing in Auckland
Trade Mission Meetings in Auckland
Conclusion of Trade Mission
V. Criteria for Participant Selection
Relevance of the company's business line to the mission
scope and goals
Potential for business in the selected markets
Timeliness of the company's completed application,
participation agreement, and payment of the mission participation fee
Provision of adequate information on the company's
products and/or services and communication of the company's primary
objectives to facilitate appropriate matching with potential business
partners
Certification that the company's products and/or services
are manufactured or produced in the United States or if manufactured/
produced outside of the United States, the product/service must be
marketed under the name of a U.S. firm and have U.S. content
representing at least 51 percent of the value of the finished good or
service.
Any partisan political activities of an applicant, including
political contributions, will be entirely irrelevant to the selection
process.
The mission will be promoted through the following venues: Export
Assistance Centers and the Healthcare Team; USCS Trade Events List
https://www.export.gov; industry newsletters; the Federal Register;
relevant trade publications; relevant trade associations; past Commerce
trade mission participants; various in-house and purchased industry
lists, and on the Commerce Department trade missions calendar: https://
www.ita.doc.gov/doctm/tmcal.html.
[[Page 14447]]
Recruitment will begin immediately and will close on July 29, 2005.
The trade mission participation fee will be US$3,500 per company. The
participation fee does not include the cost of travel and lodging.
Participation is open to the first 10 qualified U.S. companies.
Applications received after that date will be considered only if space
and scheduling constraints permit.
Contact Information
Bill Kutson, Project Manager, U.S. Commercial Service, Global Trade
Programs, U.S. Department of Commerce, Room 2012, Washington, DC 20230,
Tel: (202) 482-2839, Fax: (202) 482-0178, E-mail:
William.Kutson@mail.doc.gov.
Dated: March 14, 2005.
Nancy Hesser,
Industry Sector Manager, Office of Trade Event Programs.
[FR Doc. E5-1235 Filed 3-21-05; 8:45 am]
BILLING CODE 3510-DR-P
